The article provides an overview of cancer survivorship statistics and treatment patterns in the United States as of 2014. It highlights the increasing number of cancer survivors due to improved early detection and treatment, with an estimated 14.5 million Americans alive with a history of cancer by January 1, 2014, and this number projected to reach nearly 19 million by January 1, 2024. The most common cancers among survivors are prostate cancer (43%), colorectal cancer (9%), and melanoma (8%) for males, and breast cancer (41%), uterine corpus cancer (8%), and colon and rectum cancer (8%) for females. The age distribution of survivors varies by cancer type, with prostate cancer survivors being predominantly older (62% aged 70 or older) compared to melanoma survivors (32% aged 70 or older). The article also discusses treatment patterns, survival rates, and long-term side effects for various cancers, including breast, colorectal, leukemia, lymphoma, lung, melanoma, and prostate cancer. It emphasizes the importance of understanding the unique medical and psychosocial needs of cancer survivors and the availability of resources to support them throughout their journey.The article provides an overview of cancer survivorship statistics and treatment patterns in the United States as of 2014. It highlights the increasing number of cancer survivors due to improved early detection and treatment, with an estimated 14.5 million Americans alive with a history of cancer by January 1, 2014, and this number projected to reach nearly 19 million by January 1, 2024. The most common cancers among survivors are prostate cancer (43%), colorectal cancer (9%), and melanoma (8%) for males, and breast cancer (41%), uterine corpus cancer (8%), and colon and rectum cancer (8%) for females. The age distribution of survivors varies by cancer type, with prostate cancer survivors being predominantly older (62% aged 70 or older) compared to melanoma survivors (32% aged 70 or older). The article also discusses treatment patterns, survival rates, and long-term side effects for various cancers, including breast, colorectal, leukemia, lymphoma, lung, melanoma, and prostate cancer. It emphasizes the importance of understanding the unique medical and psychosocial needs of cancer survivors and the availability of resources to support them throughout their journey.